253 results
8-K
EX-99.1
DRRX
Durect Corp
2 Mar 15
DURECT Announces Epigenomic Regulator Program including a New NAFLD/NASH and Acute Organ Injury Product Candidate in Development
12:00am
, convenience, adherence, efficacy and safety for small molecule and biologic drugs. Late stage development programs of this nature include REMOXY® … during the course of the program, our development plans for DUR-928, and the timing and nature of future clinical trials are forward-looking statements
S-1
EX-10.12
DRRX
Durect Corp
20 Apr 00
IPO registration
12:00am
Share of all
costs, expenses, taxes, insurance, maintenance and other charges of every kind
and nature arising in connection with the Master Lease … , removals, and expenses of every type and nature,
to the extent caused by the use, storage, handling, manufacture, transportation,
release, discharge
S-1
EX-10.11
DRRX
Durect Corp
20 Apr 00
IPO registration
12:00am
proper and Tenant
shall not store or permit to be stored or otherwise place any materials of any
nature whatsoever outside the building proper. Tenant may … of every kind and nature levied or assessed in lieu of, in
substitution for, or in addition to, existing or additional taxes on the
Premises whether
S-1
EX-10.15
DRRX
Durect Corp
20 Apr 00
IPO registration
12:00am
services of any nature to any person
or organization, whether or not for compensation, provided, however, that the
Company acknowledges that Employee … nature or otherwise. I further understand that
Confidential Information does not include any of the foregoing items which has
become publicly
S-1
EX-10.16
gfnzv5a23e
20 Apr 00
IPO registration
12:00am
S-1/A
EX-10.20
hujuz zhjpf2x9
16 Jun 00
IPO registration (amended)
12:00am
S-1
EX-10.14
9whctaj5uuw5tx7kqz
20 Apr 00
IPO registration
12:00am
S-1
EX-10.7
0o01z2 b50wn4
20 Apr 00
IPO registration
12:00am
S-1
EX-10.10
i8genlzh
20 Apr 00
IPO registration
12:00am
CORRESP
sgzuxe
1 Sep 05
Correspondence with SEC
12:00am
8-K
EX-99.1
13clzw302rffa40
16 Dec 20
DURECT Corporation Announces DUR-928 Granted FDA Fast Track Designation for Treatment of Alcoholic Hepatitis
9:15am
8-K
EX-99.1
tnz5gpov8n66
10 Nov 21
Other Events
9:15am
8-K
EX-99.1
6737ll1ufap iox
7 Sep 23
DURECT Corporation Announces Last Patient Last Visit in Phase 2b AHFIRM Trial
9:02am
8-K
EX-99.1
vts7b
1 Mar 22
Other Events
9:00am
UPLOAD
hcpsl
16 Aug 05
Letter from SEC
12:00am
CORRESP
trqyfmco
29 Sep 05
Correspondence with SEC
12:00am